Icosavax, Inc.
ICVX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $63 | $155 | $49 | $59 |
| Short-Term Investments | $166 | $92 | $147 | $159 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $5 | $5 | $5 |
| Total Curr. Assets | $235 | $252 | $202 | $224 |
| Property Plant & Equip (Net) | $14 | $15 | $4 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | -$15 |
| Total NC Assets | $16 | $17 | $7 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $251 | $269 | $209 | $239 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $3 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $11 | $9 | $9 |
| Total Curr. Liab. | $13 | $15 | $13 | $14 |
| LT Debt | $6 | $6 | $7 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $6 | -$4 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $19 | $21 | $9 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$259 | -$237 | -$210 | -$186 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $491 | $485 | $411 | $404 |
| Total Equity | $232 | $248 | $200 | $218 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $251 | $269 | $209 | $239 |
| Net Debt | -$55 | -$147 | -$41 | -$50 |